SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jan. 27, 2023-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced the sale of the company’s legacy small molecule protease inhibitor
